Advances in Chronic Kidney Disease
Volume 14, Issue 3 , Pages 256-262 , July 2007

Ultrapure Dialysate for Home Hemodialysis?

  • Rosemary Ouseph
    • ,
  • Richard A. Ward

      Affiliations

    • Corresponding Author InformationAddress correspondence to Richard A. Ward, PhD, Kidney Disease Program, University of Louisville, 615 S. Preston Street, Louisville, KY 40202-1718.

References 

  1. Favero MS, Petersen NJ, Boyer KM, et al. Microbial contamination of renal dialysis systems and associated health risks. Trans Am Soc Artif Int Organs. 1974;20:175–183
  2. Ward RA. Worldwide water standards for hemodialysis. Hemodial Int. 2007;11(suppl 1):S18–S25
  3. In: Association for the Advancement of Medical Instrumentation: Water Treatment Equipment for Hemodialysis Applications (ANSI/AAMI RD62:2006). Arlington, VA: Association for the Advancement of Medical Instrumentation; 2006;p. 4
  4. In: Association for the Advancement of Medical Instrumentation: Dialysate for Hemodialysis (ANSI/AAMI RD52:2004). Arlington, VA: Association for the Advancement of Medical Instrumentation; 2004;p. 7–8
  5. Haemodialysis solution, concentrated, water for diluting. European Pharmacopoiea. (ed 5). Strasbourg: European Pharmacopoiea Commission; 2005;Monograph 2005:1167
  6. European Renal Association–European Dialysis and Transplant Association. European Best Practice Guidelines for Haemodialysis (Part I), Section IV: Dialysis fluid purity. Nephrol Dial Transplant. 2002;17(suppl 7):45–62
  7. Arduino MJ, McAllister SK, Bland LA. Assuring proper germicide concentrations in reprocessed dialyzers. Dial Transplant. 1993;22:652–656
  8. Lonnemann G, Behme TC, Lenzer B, et al. Permeability of dialyzer membranes to TNFα-inducing substances derived from water bacteria. Kidney Int. 1992;42:61–68
  9. Schindler R, Christ-Kohlrausch F, Frei U, et al. Differences in the permeability of high-flux dialyzer membranes for bacterial pyrogens. Clin Nephrol. 2003;59:447–454
  10. Weber V, Linsberger I, Rossmanith E, et al. Pyrogen transfer across high- and low-flux hemodialysis membranes. Artif Organs. 2004;28:210–217
  11. Schindler R, Beck W, Deppisch R, et al. Short bacterial DNA fragments: Detection in dialysate and induction of cytokines. J Am Soc Nephrol. 2004;15:3207–3214
  12. Leypoldt JK, Schmidt B, Gurland HJ. Net ultrafiltration may not eliminate backfiltration during hemodialysis with highly permeable membranes. Artif Organs. 1991;15:164–170
  13. Ledebo I, Nystrand R. Defining the microbiological quality of dialysis fluid. Artif Organs. 1999;23:37–43
  14. Tsuchida K, Takemoto Y, Yamagami S, et al. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and Limulus amebocyte lysate methods. Nephron. 1997;75:438–443
  15. Sitter T, Bergner A, Schiffl H. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant. 2000;15:1207–1211
  16. Schiffl H, Lang SM, Stratakis D, et al. Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant. 2001;16:1863–1869
  17. Hsu P-Y, Lin C-L, Yu C-C, et al. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients—A prospective cross-over study. J Nephrol. 2004;17:693–700
  18. Arizono K, Nomura K, Motoyama T, et al. Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis. Blood Purif. 2004;22(suppl 2):26–29
  19. Rahmati MA, Homel P, Hoenich NA, et al. The role of improved water quality on inflammatory markers in patients undergoing regular dialysis. Int J Artif Organs. 2004;27:723–727
  20. Furuya R, Kumagai H, Takahashi M, et al. Ultrapure dialysate reduces plasma levels of β2-microglobulin and pentosidine in hemodialysis patients. Blood Purif. 2005;23:311–316
  21. Matsuhashi N, Yoshioka T. Endotoxin-free dialysate improves response to erythropoietin in hemodialysis patients. Nephron. 2002;92:601–604
  22. Ouseph R, Jones S, Dhananjaya N, et al: Use of ultrafiltered dialysate is associated with improvements in hemodialysis-associated morbidity in patients treated with reused dialyzers. Nephrol Dial Transplant E-pub ahead of print March 29, 2007, doi:10.1093/ndt/gfm124
  23. Kleophas W, Haastert B, Backus G, et al. Long-term experience with ultrapure individual dialysis fluid with a batch type machine. Nephrol Dial Transplant. 1998;13:3118–3125
  24. Lederer SR, Schiffl H. Ultrapure dialysis fluid lowers the cardiovascular morbidity in patients on maintenance hemodialysis by reducing continuous microinflammation. Nephron. 2002;91:452–455
  25. Izuhara Y, Miyata T, Saito K, et al. Ultrapure dialysate decreases plasma pentosidine, a marker of “carbonyl stress”. Am J Kidney Dis. 2004;43:1024–1029
  26. Lamas JM, Alonso M, Sastre F, et al. Ultrapure dialysate and inflammatory response in haemodialysis evaluated by darbepoetin requirements—A randomized study. Nephrol Dial Transplant. 2006;21:2851–2858
  27. Ayus JC, Mizani MR, Achinger SG, et al. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: A prospective, controlled study. J Am Soc Nephrol. 2005;16:2778–2788
  28. Yeun D, Richardson RMA, Fenton SSA, et al. Quotidian nocturnal hemodialysis improves cytokine profile and enhances erythropoietin responsiveness. ASAIO J. 2005;51:236–241
  29. Mehrabian S, Morgan D, Schlaeper C, et al. Equipment and water treatment considerations for the provision of quotidian home hemodialysis. Am J Kidney Dis. 2003;42(suppl 1):66–70
  30. Clark WR, Turk JE. The NxStage System One. Semin Dial. 2004;17:167–170
  31. Twardowski ZJ. PHD®: The technological solution for daily haemodialysis?. Nephrol Dial Transplant. 2003;18:19–23
  32. Ash SR. The Allient dialysis system. Semin Dial. 2007;17:164–166

PII: S1548-5595(07)00051-1

doi: 10.1053/j.ackd.2007.03.007

Advances in Chronic Kidney Disease
Volume 14, Issue 3 , Pages 256-262 , July 2007

Article Tools

* Image Usage & Resolution